Angiogenesis in breast cancer: How should we measure this? (Review)

M. J.K. Pollitt, A. M. Hanby, K. Horgan, C. E. Murphy, P. F. Jones, V. Speirs*

*Corresponding author for this work

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

Original languageEnglish
Pages (from-to)931-936
Number of pages6
JournalOncology Reports
Volume13
Issue number5
Publication statusPublished - May 2005

Fingerprint

Breast Neoplasms
Neoplasms

Keywords

  • Angiogenesis
  • Breast cancer
  • VEGF

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Pollitt, M. J. K., Hanby, A. M., Horgan, K., Murphy, C. E., Jones, P. F., & Speirs, V. (2005). Angiogenesis in breast cancer: How should we measure this? (Review). Oncology Reports, 13(5), 931-936.

Angiogenesis in breast cancer : How should we measure this? (Review). / Pollitt, M. J.K.; Hanby, A. M.; Horgan, K.; Murphy, C. E.; Jones, P. F.; Speirs, V.

In: Oncology Reports, Vol. 13, No. 5, 05.2005, p. 931-936.

Research output: Contribution to journalReview article

Pollitt, MJK, Hanby, AM, Horgan, K, Murphy, CE, Jones, PF & Speirs, V 2005, 'Angiogenesis in breast cancer: How should we measure this? (Review)', Oncology Reports, vol. 13, no. 5, pp. 931-936.
Pollitt MJK, Hanby AM, Horgan K, Murphy CE, Jones PF, Speirs V. Angiogenesis in breast cancer: How should we measure this? (Review). Oncology Reports. 2005 May;13(5):931-936.
Pollitt, M. J.K. ; Hanby, A. M. ; Horgan, K. ; Murphy, C. E. ; Jones, P. F. ; Speirs, V. / Angiogenesis in breast cancer : How should we measure this? (Review). In: Oncology Reports. 2005 ; Vol. 13, No. 5. pp. 931-936.
@article{ac6c7893ccd048ebb805e80ae8094ab5,
title = "Angiogenesis in breast cancer: How should we measure this? (Review)",
abstract = "Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.",
keywords = "Angiogenesis, Breast cancer, VEGF",
author = "Pollitt, {M. J.K.} and Hanby, {A. M.} and K. Horgan and Murphy, {C. E.} and Jones, {P. F.} and V. Speirs",
year = "2005",
month = "5",
language = "English",
volume = "13",
pages = "931--936",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Angiogenesis in breast cancer

T2 - How should we measure this? (Review)

AU - Pollitt, M. J.K.

AU - Hanby, A. M.

AU - Horgan, K.

AU - Murphy, C. E.

AU - Jones, P. F.

AU - Speirs, V.

PY - 2005/5

Y1 - 2005/5

N2 - Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

AB - Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

KW - Angiogenesis

KW - Breast cancer

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=25144522798&partnerID=8YFLogxK

M3 - Review article

C2 - 15809760

AN - SCOPUS:25144522798

VL - 13

SP - 931

EP - 936

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 5

ER -